Roberto Caporali to Janus Kinase Inhibitors
This is a "connection" page, showing publications Roberto Caporali has written about Janus Kinase Inhibitors.
Connection Strength
0.274
-
COVID-19 revisiting inflammatory pathways of arthritis. Nat Rev Rheumatol. 2020 08; 16(8):465-470.
Score: 0.138
-
What is the true incidence of COVID-19 in patients with rheumatic diseases? Ann Rheum Dis. 2021 02; 80(2):e18.
Score: 0.136